Comparison of efficacies of ondansetron and dixyrazine for prophylaxis of emesis during induction treatment in acute myelogenous leukemia - A pilot study

Acta Oncologica

Volumn 36, Issue 2, 1997, Pages 229-230

  Sundström, Gunnel M ^a   Wahlin, Anders ^a  

^a UMEÅ UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

AMSACRINE; ANTINEOPLASTIC AGENT; CYTARABINE; DIXYRAZINE; ETOPOSIDE; ONDANSETRON;

ACUTE GRANULOCYTIC LEUKEMIA; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SHORT SURVEY; VOMITING;

EID: 0030889166     PISSN: 0284186X     EISSN: None     Source Type: Journal    
DOI: 10.3109/02841869709109237     Document Type: Short Survey

References (7)

1. Coates A, Abrahams S, Kaye B, et al. On the receiving end-patient perception of the side-effects of cancer chemotherapy. Eur J Cancer Clin Oncol 1983; 19: 203-8.
2. Larsson S, Jonmarker C. Postoperative emesis after pediatric strabismus surgery: the effect of dixyrazine compared to dridol. Acta Anaesthesiol Scand 1990; 34: 227-30.
3. Sorbe B, Hallén C. Antiemetic treatment of chemotherapy-induced nausea in ovarian carcinoma patients. Gynecol Oncol 1989; 34: 141-4.
4. Kris MG, Gralla RJ, Clark RA, et al. Consecutive dose-finding trials adding lorazepam to the combination of metoclopramide plus dexametasone, improved subjective effectiveness over the combination of diphenhydramine plus metoclopramide plus dexamethasone. Cancer Treat Rep 1985; 69: 1257-62.
5. Jones AL, Hill AS, Soukop M, et al. Comparison of dexamethasone and ondansetron in prophylaxis of emesis induced in moderately emetogenic chemotherapy. Lancet 1991; 338: 483-7.
6. Kaye BS. Antiemetic therapy - Where do we go from here? Ann Oncol 1993; 4: 443-5.
7. Linley CM, Bernard S, Fields SM. Incidence and duration of chemotherapy-induced nausea and vomiting in the outpatient oncology populations. J Clin Oncol 1989; 7: 1142-9.